TLSA · Tiziana Life Sciences Ltd
$0.96
-0.01 (-0.74%)
At close · Jul 29
Market Cap
$123.09M
Shares
127.26M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.96
Open$0.96
Day$0.94–1.02
52W$0.87–2.60
Avg vol 30d232K
Short int1.2M · 1.0% float · 4.6d
Short vol57%
DataJan 2020–Jul 2026
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Strong Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Bullish
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 20.7 · elevated
Equity put/call 0.61
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−34%
below
Price vs 50-day avg
−21%
below
RSI (14)
40
neutral
MACD trend
Negative
52-week position
5%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−25%
trailing
6-month return
−30%
trailing
YTD return
−36%
this year
Relative strength
−37%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow
Accumulating
9 of 33 funds reported for Jun 30 · net +359.6K sh shares · +3 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.98% of float · ▼ -20.4% MoM · 4.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
33 holders — near 3-yr high, broad support
Squeeze score
38
low risk · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
82%
annualized · 1-yr
Max drawdown
−64%
past year
ATR
11.6%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−34%
Bearish
Price vs 50-day avg
−21%
Bearish
RSI (14)
40
Neutral
MACD trend
Negative
Bearish
52-week position
5%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow
Accumulating
9 of 33 funds reported for Jun 30 · net +359.6K sh shares · +3 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.98% of float · ▼ -20.4% MoM · 4.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
33 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $1
Now $1 · 5%
52-wk high $3
vs 200-day avg -34%
vs 50-day avg -21%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
TLSA
this stock
Tiziana Life Sciences Ltd
|
$123.09M | -35.6% | — | — | 1.0% |
|
ONC
BeOne Medicines Ltd.
|
$472.90B | +8.8% | +22179.2% | 962.4 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$124.46B | +6.6% | +46.2% | 29.1 | 2.0% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$72.88B | -9.8% | +20.8% | 17.0 | 3.3% |
|
ARGX
Argenx SE
|
$54.57B | +4.9% | — | — | 2.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Accumulating
Holders
36
- % held
- 2.8%
- Reported
- 9 of 33
- Top holder
- Dauntless Investment Grou…
Held
Float
Short & Settlement
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| TLSA | +1.1% | -25.0% | -30.4% | -25.0% | -35.6% |
| SPY | -2.4% | -2.3% | +6.3% | -2.3% | +7.0% |
| vs SPY | +3.5% | -22.7% | -36.7% | -22.7% | -42.5% |